FDA Investigator Mei Chiung J Huang
Mei Chiung J Huang has inspections in 4 countries as of 01 Sep 2023. Mei Chiung J Huang has collaborated with a combinined 2188 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
Switzerland
Co-Investigator(s):
Abdur Razzaque,
Ademola O Daramola,
Alexandra B Pitkin,
Angela D Wise,
Anjali Shukla, PhD,
Ann L Demarco,
Anthony C Warchut,
Azza Talaat,
Bernice F Hirsch,
Bradley J Maunder,
Breena L D'ambrogi,
Brentley S Collins,
Bruce H Mccullough,
Bryan L Mcguckin,
Camacho,
Capri R Woolridge,
Carolyn E Barney,
Carr Sharpe,
Catherine J Laufmann,
CDR Rochelle B Young, RPh, MSA,
Charles I Ann,
Christian D Lynch (CDL),
Christine M Parmentier,
Christopher T Middendorf,
Comyar Shoghi,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia M Goudeau,
Daniel C Geffin,
Daniel J Roberts,
David G Eng,
David M Beltran,
Davis,
Dawn M Braswell,
Desiree C Iya,
Doan T Nguyen, PharmD,
Don H Bark, PhD,
Dr. Guang Gao, PhD,
Dr. Ralph M Bernstein, PhD,
Edmund F Mrak, Jr,
Edna J Hidalgo,
Eileen A Liu,
Emal Wahab,
Emil P Wang, JD,
Eric M Mueller, PharmD,
Erin D Mccaffery,
Francisco,
Gary L Hartman,
Gene D Arcy,
Gwyn G Dickinson,
Henry K Lau,
Jacqueline Mdiaz Albertini,
James C Lee, PharmD,
James C Maclaughlin,
James C Yee,
James L Finn,
Jeffrey D Meng,
Jeffrey M Watson,
Jennifer S King,
Jeremy Beber,
Joan T Briones,
Jocelyn T Ramos,
Judy C Nepsa,
Kalavati Suvarna, PhD,
Karla J Gibler,
Kent C Faul,
Kevin D Kallander,
Kevin Obrien,
Kevin P Foley,
Kham Phommachanh,
Kim Lthomas Cruse,
Lance M De Souza, MBA,
LCDR Debra Emerson,
Leongc,
Linda M Cheny,
Linda S Shook,
Lucila B Nwatu,
Lydia S Chan,
Macropolk,
Mariza M Jafary,
Mary C Acton,
Megan E Kulas,
Mei Chiung Huang (Jo),
Michele Gottshall,
Michele L Forster, PhD,
Michele L Obert,
Mihaly S Ligmond,
Mra Davism,
Nabeela J Chaudhry,
Nicholas L Paulin,
Nicole Yuen,
Omotunde O Osunsanmi,
Patricia A Cochran,
Patricia H Dlugosz,
Paula A Trost,
Phung,
Prabhu P Raju,
Randy L Self,
Rebecca Rodriguez,
Regina T Brown,
Robert C Coleman,
Romero,
Saied A Asbagh,
Samina S Khan,
Samuel T Walker,
Sandra S Saniga,
Sarah A Hassas,
Scott N Lim,
Seneca D Toms,
Shawn R Gould,
Sidney B Priesmeyer,
State Agency,
Stephanie A Slater, MS,
Stephanie L Kelly,
Steven C Himebaugh,
Sundy Ven,
Susan M Jackson,
Susan O Oladeji,
Thomas A Peter,
Tracy K Li,
Travis S Bradley,
Truong Xuan Nguyen (Andy),
Vlada Matusovsky,
Wayne E Seifert,
Xiaokuang Lai, PhD,
Yumi J Hiramine,
Zhong Li, PhD
Mei Chiung J Huang's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2008 | EIR | Grifols Diagnostic Solutions Inc. - EIR, 2008-02-01 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more